Anxiety Rx for Mental Disorder: 10.0% of denials overturned
In 20 California IMR decisions from 2019 to 2025, reviewers overturned 2 (10.0%). In the last five years: 0.0% of 10. 19 were medical-necessity disputes, 1 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 4 | 0.0% |
| 2022 | 1 | 0.0% |
| 2023 | 2 | 0.0% |
| 2024 | 1 | 0.0% |
| 2025 | 2 | 0.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 9 | 22.2% | 10.0% |
| Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial). | 4 | 0.0% | 10.0% |
| Guidelines or criteria citedThe findings cite guidelines, criteria or a standard of care. | 3 | 0.0% | 10.0% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“Nature of Statutory Criteria/ Case Summary: The enrollee is requesting authorization and coverage for a three month refill of Effexor 150mg, a three month refill of Seroquel 200mg, individual psychotherapy every two weeks, and monthly visits with a psychiatrist. The enrollee has chronic recurrent depression and anxiety, exacerbated by recent stressors. Her symptoms were relatively well-managed until she had a …”
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for clonazepam 0.5 mg. Medical literature notes that benzodiazepines with an intermediate to long onset of action such as clonazepam might have “less potential for abuse and less risk of rebound” and thus helpful for chronic management of GAD. One study reported that clonazepam can be “successfully discontinued …”
And one the reviewer upheld
“The physician reviewer found that a patient has requested authorization and coverage for Xanax. Per the medical records, the patient has diagnoses of generalized and social anxiety disorders and a history of severe alcohol use disorder, in remission. Current medical literature and clinical guidelines advise against prescribing benzodiazepines, including alprazolam, as therapy for anxiety disorders in patients with a history …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Anxiety Rx denials for Mental Disorder overturned?
In 20 California IMR decisions from 2019 to 2025, reviewers overturned 2 (10.0%). In the last five years: 0.0% of 10. 19 were medical-necessity disputes, 1 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.